Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Management of anoperineal lesions in Crohn's disease: a French National Society of Coloproctology national consensus.

Literature DB >> 30604249

Management of anoperineal lesions in Crohn's disease: a French National Society of Coloproctology national consensus.

D Bouchard¹, F Pigot², G Staumont³, L Siproudhis⁴, L Abramowitz⁵, P Benfredj⁶, C Brochard⁴, N Fathallah⁶, J-L Faucheron⁷, T Higuero⁸, Y Panis⁹, V de Parades⁶, B Vinson-Bonnet¹⁰, D Laharie¹¹.

Abstract

The French National Society of Coloproctology established national recommendations for the treatment of anoperineal lesions associated with Crohn's disease. Treatment strategies for acute abscesses, active fistulas (active denovo and still active under treatment), fistulas in remission, and rectovaginal fistulas are suggested. Recommendations have been graded following the international recommendations, and when absent, professional agreement has been established. For each situation, practical algorithms have been drawn.

Entities: Disease

Keywords: Anal fistula; Crohn’s disease; Treatment

Mesh：

Year: 2019 PMID： 30604249 DOI： 10.1007/s10151-018-1906-y

Source DB: PubMed Journal: Tech Coloproctol ISSN： 1123-6337 Impact factor: 3.781

70 in total

1. Is biological mesh interposition a valid option for complex or recurrent rectovaginal fistula?

Authors: D Mege; M Frasson; L Maggiori; Y Panis
Journal: Colorectal Dis Date: 2016-02 Impact factor: 3.788

Review 2. Systematic review: the combined surgical and medical treatment of fistulising perianal Crohn's disease.

Authors: N A Yassin; A Askari; J Warusavitarne; O D Faiz; T Athanasiou; R K S Phillips; A L Hart
Journal: Aliment Pharmacol Ther Date: 2014-08-13 Impact factor: 8.171

3. Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure.

Authors: Ana Echarri; Javier Castro; Manuel Barreiro; Daniel Carpio; Santos Pereira; Aurelio Lorenzo
Journal: J Crohns Colitis Date: 2010-09-17 Impact factor: 9.071

4. Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors: Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal: N Engl J Med Date: 2010-04-15 Impact factor: 91.245

5. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease.

Authors: A Haennig; G Staumont; B Lepage; P Faure; L Alric; L Buscail; B Bournet; J Moreau
Journal: Colorectal Dis Date: 2015-04 Impact factor: 3.788

6. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas.

Authors: D A Schwartz; M J Wiersema; K M Dudiak; J G Fletcher; J E Clain; W J Tremaine; A R Zinsmeister; I D Norton; L A Boardman; R M Devine; B G Wolff; T M Young-Fadok; N N Diehl; J H Pemberton; W J Sandborn
Journal: Gastroenterology Date: 2001-11 Impact factor: 22.682

7. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study.

Authors: B E Sands; M A Blank; R H Diamond; J P Barrett; S J Van Deventer
Journal: Aliment Pharmacol Ther Date: 2006-04-15 Impact factor: 8.171

8. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.

Authors: Guillaume Bouguen; Laurent Siproudhis; Emmanuel Gizard; Timothée Wallenhorst; Vincent Billioud; Jean-François Bretagne; Marc-André Bigard; Laurent Peyrin-Biroulet
Journal: Clin Gastroenterol Hepatol Date: 2013-01-30 Impact factor: 11.382

9. Vedolizumab as induction and maintenance therapy for Crohn's disease.

Authors: William J Sandborn; Brian G Feagan; Paul Rutgeerts; Stephen Hanauer; Jean-Frédéric Colombel; Bruce E Sands; Milan Lukas; Richard N Fedorak; Scott Lee; Brian Bressler; Irving Fox; Maria Rosario; Serap Sankoh; Jing Xu; Kristin Stephens; Catherine Milch; Asit Parikh
Journal: N Engl J Med Date: 2013-08-22 Impact factor: 91.245

10. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.

Authors: Jacques Cosnes; Anne Bourrier; David Laharie; Stéphane Nahon; Yoram Bouhnik; Franck Carbonnel; Matthieu Allez; Jean-Louis Dupas; Jean-Marie Reimund; Guillaume Savoye; Pauline Jouet; Jacques Moreau; Jean-Yves Mary; Jean-Frédéric Colombel
Journal: Gastroenterology Date: 2013-04-30 Impact factor: 22.682

5 in total

1. Management of perianal fistula in inflammatory bowel disease: identification of prognostic factors associated with surgery.

Authors: Sara Gortázar de Las Casas; Mario Alvarez-Gallego; Jose Antonio Gazo Martínez; Natalia González Alcolea; Cristina Barragán Serrano; Aitor Urbieta Jiménez; María Dolores Martín Arranz; Jose Luis Marijuan Martín; Isabel Pascual Migueláñez
Journal: Langenbecks Arch Surg Date: 2021-01-30 Impact factor: 3.445

Review 2. Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): Crohn's disease.

Authors: G Pellino; D S Keller; G M Sampietro; I Angriman; M Carvello; V Celentano; F Colombo; F Di Candido; S Laureti; G Luglio; G Poggioli; M Rottoli; S Scaringi; G Sciaudone; G Sica; L Sofo; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal: Tech Coloproctol Date: 2020-03-14 Impact factor: 3.781